HOME >> MEDICINE >> NEWS
Melanoma research receives a massive funding boost

NSW cancer researchers from the Sydney Melanoma Unit have received over $11 million to advance their world-leading research into the diagnosis and treatment of melanoma.

Australians have the highest rate of melanoma in the world, with incidence levels up to four times higher than the US and the UK, and up to ten times higher than most other countries.

Whilst it is the third most common cancer in Australia, it has proved to be one of the most difficult to manage. It most commonly affects those in the 30-45 year age group - people in the prime of their life- yet standard cancer treatments are often ineffective.

The Sydney Melanoma Unit is a group of cancer researchers and clinicians drawn from Westmead Millennium Institute, Newcastle Mater and Royal Prince Alfred Hospitals. It runs the largest melanoma treatment centre in the world, and with associated expertise in molecular diagnosis and treatment, provides our best hope for improving outcomes in people who develop, or are at risk of developing, melanoma.

This research group was recently recognised with a $3.75 million Program Grant from the Cancer Institute NSW. Today the Hon Tony Abbott, Commonwealth Minister for Health, announced that the Unit has also been awarded a prestigious National Health and Medical Research Council Program Grant, providing a further $7.8 million to support its vital research.

"Melanoma cells that have spread from their site of origin are notorious for being resistant to cancer treatment such as chemotherapy and radiotherapy" says Professor Richard Kefford, Chief Investigator of the successful Sydney Melanoma Unit NHMRC grant and researcher at Westmead Millennium Institute.

"These funds will allow us to progress our research into the molecular factors that determine an individual's risk of melanoma, so that we can identify the type of melanoma they have and how that disease will respond to treatments. We can then create more effective treatme
'"/>

Contact: Gayle McNaught
gayle_mcnaught@wmi.usyd.edu.au
61-298-459-009
Research Australia
6-Jul-2005


Page: 1 2

Related medicine news :

1. Summer update: Melanoma research progress suggests optimism for future cures
2. Melanoma vaccine strategy shows promise in laboratory experiments
3. Melanoma risk only partially associated vith exposure to UVB from sunlight
4. 1 of 2 pediatric kidney disease research centers in world established
5. Stanford researchers find culprit in aging muscles that heal poorly
6. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
7. Indiana University Imaging Center receives $6M grant for kidney research
8. Penn researchers discover novel pathway for increasing good cholesterol
9. New research discovers independent brain networks control human walking
10. Theory of facial aging gets a facelift from UT Southwestern researchers
11. Sports concussion research using fMRI provides insight for safe return-to-play decisions

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Melanoma research receives massive funding boost

(Date:7/31/2015)... ... 2015 , ... When the weather turned hot and warm-season turfgrasses, such as ... called Leisure Time(TM) zoysia . It's nicknamed LTZ(TM) for short. Incidentally, both names ... new type of sod, Super-Sod is giving away red Adirondack chairs with the Leisure ...
(Date:7/31/2015)... ... 31, 2015 , ... Precision Aesthetics is New York’s only Thermage skin tightening ... first provider of Exilis non-surgical fat reduction in New York. Due to its ... large International clientele. Many patients travel to New York to get their non-surgical ...
(Date:7/31/2015)... ... July 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the arrival ... Zeltiq Aesthetics released this new applicator in the United States as an upgrade to ... thighs. The original applicator required a 2 hour treatment time. The new ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Coco Libre ... athletes, judges, media, and VIPs at the 2015 Vans US Open of Surfing, July ... water that can claim “no added sugar” on the market, is a natural choice ...
(Date:7/31/2015)... CA (PRWEB) , ... July 31, 2015 , ... According ... and cosmetic experts gathered to see if they could reach a consensus on the ... breast augmentation and facelifts. Overall, the group reached 90 percent consensus on a series ...
Breaking Medicine News(10 mins):Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3
(Date:7/30/2015)...  Unichem Pharmaceuticals ( USA ), Inc. ... 25 mg 1000-count bottle to the consumer level. This ... to the identification of a Clopidogrel tablet found in ... risk associated with mistakenly taking a Clopidogrel tablet instead ... experiencing Clopidogrel,s side effects which include bleeding and/or bruising. ...
(Date:7/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) today announced ... director of Warburg Pincus LLC, to the Amgen Board of ... Fred Hassan and the deep, global experience he brings ... Robert A. Bradway , chairman and chief executive officer of Amgen. ... serve Amgen well." Mr. Hassan has been Partner ...
(Date:7/30/2015)... -- Growth of the U.S. nonprescription market is primarily driven ... to the OTC market. Due to an increasingly favorable ... activity over the next five years with several all ... entering the market into existing categories. If ... those with low to moderate likelihood), the market is ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
Cached News: